Degarelix

Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression

Items (National)
32.3K
NHS Cost
£3.9M
Practices
1,863
Avg per Practice
17

Overview

Degarelix is prescribed by 1,863 GP practices across England. In the last 12 months, 32,333 items were prescribed at a total cost of £3,863,209 to the NHS. It is classified under BNF Chapter Malignant Disease and Immunosuppression, Section Sex hormones and hormone antagonists in malignant disease.

Monthly Prescribing Trend

No monthly data available.

Prescribing by Area

AreaItemsPracticesAvg/Practicevs National
S 2,651 83 32 +83.3% ▲
PO 2,589 48 54 +209.8% ▲
NE 1,981 73 27 +55.7% ▲
TS 1,887 59 32 +83.9% ▲
LE 1,587 58 27 +57.5% ▲
DL 1,299 35 37 +113.2% ▲
DE 1,208 44 28 +58.0% ▲
PR 1,165 42 28 +59.2% ▲
BB 1,134 40 28 +63.2% ▲
DH 1,089 28 39 +123.6% ▲
PE 992 37 27 +54.0% ▲
LA 780 19 41 +136.2% ▲
SS 759 27 28 +61.5% ▲
SR 738 21 35 +101.7% ▲
LN 700 26 27 +54.6% ▲
OX 571 28 20 +17.2% ▲
CW 474 20 24 +36.2% ▲
LS 450 25 18 +3.4% ▲
CA 417 15 28 +59.8% ▲
BN 393 17 23 +32.8% ▲

Top Prescribing Practices

Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.